Riskpilot← Back to searchSign inGet full accessJYLLINGE FYSIOTERAPI ApS
APSActiveCVR 27768288Jyllingecentret 6Physiotherapy activities · NACE 8695Est. 20046 employeeswww.jyllinge-fysioterapi.dk
Revenue 2025
DKK 4,1M
+2% vs 2024
EBITDA margin
12.7%
+11% vs 2024
Equity ratio
49.5%
Financial strength
Net profit 2025
DKK 380K
+10% vs 2024
| Revenue | DKK 4,1M | +2% |
| EBITDA | DKK 524K | +11% |
| Net profit | DKK 380K | +10% |
| Total assets | DKK 809K | -23% |
| Equity | DKK 400K | -32% |
| Employees | 6 | — |
Legal name
JYLLINGE FYSIOTERAPI ApS
CVR number
27768288
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
2. juni 2004
Share capital
DKK 20.000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør og et bestyrelsesmedlem i forening eller af to bestyrelsesmedlemmer i forening
Company purpose
Selskabets formål er at udføre fysioterapeutiske behandlinger fra selskabets adresse eller hjemmebehandlinger
Address
Jyllingecentret 6
Phone
+4546733004
Email
info@jyllinge-fysioterapi.dk
Website
www.jyllinge-fysioterapi.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 3.574 | 3.460 | 3.798 | 3.284 | 3.218 | 3.076 | 3.067 | 3.175 | 3.788 | 3.318 | 3.899 | 4.063 | 4.134 |
| Staff expenses | -0 | -2.625 | -2.578 | -2.702 | -3.037 | -2.968 | -2.988 | -3.121 | -2.986 | -3.273 | -3.362 | -3.263 | -3.588 | -3.610 |
| EBITDA | 0 | 116 | 32 | 254 | 247 | 250 | 88 | -55 | 188 | 515 | -43 | 636 | 474 | 524 |
| Depreciation & amort. | -0 | -267 | -270 | -39 | -16 | -16 | -34 | -41 | -44 | -44 | -56 | -42 | -33 | -27 |
| EBIT | 0 | -151 | -238 | 215 | 231 | 234 | 54 | -96 | 144 | 470 | -99 | 594 | 441 | 497 |
| Net financials | 0 | -28 | -60 | -34 | -27 | -8 | -29 | -40 | -36 | -10 | -10 | -15 | -1 | -2 |
| Profit before tax | 0 | -179 | -298 | 181 | 204 | 226 | 25 | -136 | 108 | 460 | -109 | 578 | 439 | 496 |
| Tax | -0 | -46 | -64 | 43 | 48 | 50 | 14 | -25 | 19 | 107 | -22 | 128 | 95 | 116 |
| Net profit | 0 | -133 | -234 | 138 | 156 | 176 | 11 | -111 | 88 | 353 | -87 | 450 | 344 | 380 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 57 | 909 | 669 | 540 | 650 | 664 | 920 | 936 | 1.056 | 880 | 785 | 987 | 1.045 | 809 |
| Equity | 352 | 27 | -207 | -70 | 86 | 262 | 152 | 41 | 130 | 483 | 196 | 646 | 590 | 400 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 845 | 876 | 610 | 563 | 402 | 767 | 895 | 926 | 397 | 590 | 341 | 455 | 408 |
| Total debt | 0 | 845 | 876 | 610 | 563 | 402 | 767 | 895 | 926 | 397 | 590 | 341 | 455 | 408 |
EBITDA margin
12.7%
This company
15.8%
Market median
-20% vs market
20122025
Equity ratio
49.5%
This company
38.2%
Market median
+30% vs market
20122025
Return on equity
94.9%
This company
18.4%
Market median
+416% vs market
20122025
Net profit margin
9.2%
This company
8.1%
Market median
+14% vs market
20122025
Asset turnover
5.11×
This company
1.12×
Market median
+356% vs market
20122025
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AH Chief Executive Officer | Chief Executive Officer | 2004 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2004 | — | — | |
| Chairman | 2025 | — | — | |
| Chairman | 2004 | — | — | |
| Board of Directors | 2004 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Jyllinge Holding Autoriseret Fysioterapi ApS | Company | 100.0% | 100.0% | 2025 |
HDJ Holdings ApS | Company | 25.0% | 25.0% | 2025 |
Jyllinge Fysioterapi Holding ApS | Company | 100.0% | 100.0% | 2019 |
| Individual | 25.0% | 25.0% | 2004 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Jyllinge Holding Autoriseret Fysioterapi ApS
JYLLINGE FYSIOTERAPI ApS Board members of JYLLINGE FYSIOTERAPI ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Annemette Heller | Chief Executive Officer | 0 companies |
| René Popp Mortensen | Board of Directors | 0 companies |
| Frank Skade-Nielsen | Chairman | 0 companies |
| Kim Madsen | Chairman | 0 companies |
| Mads Ambjørn | Board of Directors | 0 companies |